Variant report
Variant | nsv1029043 |
---|---|
Chromosome Location | chr9:24849048-24906802 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:39)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:39 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BACH1 | chr9:24870645-24870801 | H1-hESC | embryonic stem cell: | n/a | n/a |
2 | CTCF | chr9:24888354-24888427 | Kidney_OC | kidney: | n/a | n/a |
3 | CTCF | chr9:24877760-24877910 | GM06990 | blood: | n/a | n/a |
4 | CTCF | chr9:24863988-24864090 | Kidney_OC | kidney: | n/a | n/a |
5 | E2F4 | chr9:24872976-24873062 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | FAM48A | chr9:24903429-24903636 | GM12878 | blood: | n/a | n/a |
7 | FOS | chr9:24879350-24879364 | MCF10A-Er-Src | breast: | n/a | n/a |
8 | FOXA1 | chr9:24881167-24881436 | T-47D | breast: | n/a | chr9:24881198-24881210 chr9:24881188-24881200 |
9 | GATA2 | chr9:24901406-24901762 | SH-SY5Y | brain: | n/a | chr9:24901591-24901600 |
10 | JUND | chr9:24883733-24883817 | HepG2 | liver: | n/a | chr9:24883780-24883788 chr9:24883779-24883788 chr9:24883778-24883789 chr9:24883781-24883788 |
11 | JUND | chr9:24853849-24853962 | H1-hESC | embryonic stem cell: | n/a | n/a |
12 | MAFK | chr9:24851055-24851304 | HepG2 | liver: | n/a | n/a |
13 | MAFK | chr9:24862496-24862574 | HepG2 | liver: | n/a | n/a |
14 | MAFK | chr9:24870661-24870810 | H1-hESC | embryonic stem cell: | n/a | n/a |
15 | MAFK | chr9:24858604-24858687 | HepG2 | liver: | n/a | n/a |
16 | MAFK | chr9:24882443-24882497 | HepG2 | liver: | n/a | n/a |
17 | MAZ | chr9:24895927-24896127 | HepG2 | liver: | n/a | n/a |
18 | POLR2A | chr9:24901381-24902060 | H1-neurons | neurons: | n/a | n/a |
19 | POLR2A | chr9:24854106-24854185 | GM12878 | blood: | n/a | n/a |
20 | POLR2A | chr9:24883770-24883958 | MCF10A-Er-Src | breast: | n/a | n/a |
21 | POLR2A | chr9:24867416-24867616 | MCF10A-Er-Src | breast: | n/a | n/a |
22 | POLR2A | chr9:24875494-24875694 | MCF10A-Er-Src | breast: | n/a | n/a |
23 | POLR2A | chr9:24853754-24854025 | H1-hESC | embryonic stem cell: | n/a | n/a |
24 | POLR2A | chr9:24901342-24902038 | H1-neurons | neurons: | n/a | n/a |
25 | POLR2A | chr9:24882394-24882719 | H1-neurons | neurons: | n/a | n/a |
26 | POLR2A | chr9:24879516-24879987 | MCF10A-Er-Src | breast: | n/a | n/a |
27 | POLR2A | chr9:24853707-24854059 | H1-hESC | embryonic stem cell: | n/a | n/a |
28 | POLR2A | chr9:24900091-24900662 | H1-neurons | neurons: | n/a | n/a |
29 | POLR2A | chr9:24899134-24899209 | MCF10A-Er-Src | breast: | n/a | n/a |
30 | POLR2A | chr9:24900181-24900615 | H1-neurons | neurons: | n/a | n/a |
31 | POLR2A | chr9:24861679-24861871 | MCF10A-Er-Src | breast: | n/a | n/a |
32 | RAD21 | chr9:24853766-24853974 | H1-hESC | embryonic stem cell: | n/a | n/a |
33 | REST | chr9:24901102-24901985 | H1-neurons | neurons: | n/a | n/a |
34 | REST | chr9:24900048-24900625 | H1-neurons | neurons: | n/a | n/a |
35 | REST | chr9:24899842-24900801 | H1-neurons | neurons: | n/a | n/a |
36 | STAT3 | chr9:24850877-24850993 | MCF10A-Er-Src | breast: | n/a | n/a |
37 | STAT3 | chr9:24886824-24887018 | MCF10A-Er-Src | breast: | n/a | n/a |
38 | STAT3 | chr9:24886172-24886330 | MCF10A-Er-Src | breast: | n/a | n/a |
39 | TCF12 | chr9:24853812-24853992 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:43095024..43096022-chr9:24882323..24882823,2 | MCF-7 | breast: | |
2 | chr9:24837279..24839630-chr9:24850767..24853315,2 | MCF-7 | breast: | |
3 | chr2:88301087..88301608-chr9:24880154..24880654,2 | MCF-7 | breast: | |
4 | chr9:24844439..24846773-chr9:24846853..24849105,2 | MCF-7 | breast: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-IFT74-10 | chr9:24905467-24905733 | NONHSAT130497 |
No data |
No data |
Variant related genes | Relation type |
---|---|
RMRPP5 | TF binding region |
ENSG00000216088 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs113502801 | chr9:24855612-24855613 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
2 | rs533606401 | chr9:24855640-24855641 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
3 | rs146164783 | chr9:24855644-24855645 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
4 | rs560323551 | chr9:24855656-24855657 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
5 | rs78042205 | chr9:24855665-24855666 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
6 | rs542603323 | chr9:24855672-24855673 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
7 | rs562384015 | chr9:24855727-24855728 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
8 | rs533042375 | chr9:24855729-24855730 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
9 | rs192724687 | chr9:24855730-24855731 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
10 | rs564636464 | chr9:24855746-24855747 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
11 | rs10966502 | chr9:24855762-24855763 | Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs540859362 | chr9:24855792-24855793 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
13 | rs73642218 | chr9:24873053-24873054 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs111440711 | chr9:24875497-24875498 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs117398543 | chr9:24875503-24875504 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs558754771 | chr9:24875513-24875514 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs150230434 | chr9:24875539-24875540 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs191525766 | chr9:24875552-24875553 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs374515843 | chr9:24875557-24875558 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs565971932 | chr9:24875567-24875568 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs149358853 | chr9:24875608-24875609 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs527296883 | chr9:24875617-24875618 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs548385795 | chr9:24875663-24875664 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs568028574 | chr9:24875671-24875672 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs117969224 | chr9:24877764-24877765 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs62570837 | chr9:24877765-24877766 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs554753836 | chr9:24877771-24877772 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs190708703 | chr9:24877777-24877778 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs145183358 | chr9:24879303-24879304 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs538441138 | chr9:24879357-24879358 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs543012755 | chr9:24879375-24879376 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs138961486 | chr9:24879386-24879387 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs192147838 | chr9:24879387-24879388 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs572030353 | chr9:24879403-24879404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs562617015 | chr9:24879409-24879410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs531673118 | chr9:24879442-24879443 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs551887417 | chr9:24879453-24879454 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs571542380 | chr9:24879487-24879488 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs542734074 | chr9:24879488-24879489 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs7850207 | chr9:24879489-24879490 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs73481656 | chr9:24879511-24879512 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs567575891 | chr9:24879544-24879545 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs142027781 | chr9:24879548-24879549 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs58742615 | chr9:24879549-24879550 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs397961984 | chr9:24879563-24879564 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs79994793 | chr9:24879623-24879624 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs200686600 | chr9:24879624-24879625 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs576004811 | chr9:24879660-24879661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs10966521 | chr9:24879695-24879696 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs73642219 | chr9:24879733-24879734 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Cancer | 22183965 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Glioblastoma multiforme | 22291905 | CNVD |
Lung cancer | 21911935 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
head and neck squamous cell carcinoma | 21798897 | CNVD |
Cancer | 21253487 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Glioma | 17123091 | CNVD |
Mental retardation | 17124404 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Leukemia | 19602459 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Leukemia | 18688285 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Coronary Disease | 20032323 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21732550 | CNVD |
Gastric cancer | 22539939 | CNVD |
Cancer | 21183584 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cervical cancer | 21062161 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Glioblastoma | 17090523 | CNVD |
Lung cancer | 16773561 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Bladder cancer | 19088036 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 16977458 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Chagasic megaesophagus | 20163722 | CNVD |
Melanoma | 19566914 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
Melanoma | 17363583 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21364760 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Lung cancer | 21569311 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:24855600-24855800 | Bivalent Enhancer | ES-I3 Cell Line | embryonic stem cell |
2 | chr9:24879200-24880000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
3 | chr9:24879200-24880200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
4 | chr9:24879200-24880600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
5 | chr9:24879400-24880000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr9:24879600-24880400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr9:24879600-24880400 | Enhancers | Fetal Heart | heart |
8 | chr9:24879600-24882000 | Enhancers | HMEC | breast |
9 | chr9:24879800-24882200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
10 | chr9:24879800-24882200 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
11 | chr9:24880000-24880200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
12 | chr9:24880000-24881000 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
13 | chr9:24880000-24881200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
14 | chr9:24880200-24880800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
15 | chr9:24880200-24881200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
16 | chr9:24880200-24881600 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
17 | chr9:24880400-24880800 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
18 | chr9:24880600-24881000 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
19 | chr9:24880800-24882200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
20 | chr9:24881000-24882000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
21 | chr9:24881000-24882200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
22 | chr9:24881200-24881600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
23 | chr9:24881200-24882000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
24 | chr9:24881600-24882000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
25 | chr9:24881800-24882400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
26 | chr9:24897800-24898000 | Enhancers | Gastric | stomach |
27 | chr9:24898400-24901800 | Enhancers | Fetal Heart | heart |
28 | chr9:24901800-24907400 | Weak transcription | Fetal Heart | heart |